KIDRON NADAV - Insider Non-Derivative Transactions at ORAMED PHARMACEUTICALS INC. (ORMP) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 4, 2024, KIDRON NADAV's relationship to ORAMED PHARMACEUTICALS INC. (ORMP) is Director,Officer (President and CEO), and currently has 1,781,098 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ORMP insiders.

Data Source: SEC.
KIDRON NADAV - Insider Non-Derivative Transactions of ORMP Common Stock
KIDRON NADAV - Insider Non-Derivative Transactions at ORMP
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 5, 2024 Acquisition -- (Common Stock) 329000 0 1781098
May 27, 2023 Acquisition -- (Common Stock) 120000 0 1452098
Apr 18, 2023 Acquisition -- (Common Stock) 279000 0 1332098
Mar 17, 2023 P -- (Common Stock) 26000 2.04 126000
Mar 15, 2023 P -- (Common Stock) 100000 2.01 100000